Infectious Diseases – News and Features

MIGENIX will develop anti-infective disease therapies using GenomeQuest™'s 50 million patented sequences.

BioTrove’s high-throughput technology will enable the researchers to investigate human cellular response to chemical weapons and adult stem cell differentiation.

The Institute will no longer be organized under the two research divisions TIGR and TCAG, but will now encompass an administrative team and several research groups.

The contract will enable Transgenomic to utilize its expertise in genetic variant in malignant neoplasia detection to assist OSI Pharmaceuticals in its development efforts.

Inovio’s Executive Director will present key aspects of non-viral DNA delivery at Arrowhead Drug Delivery 2007 in San Francisco.

Genome scientist and microbiologist Claire M. Fraser-Liggett has been named to head the Institute of Genome Sciences at UMB BioPark.

Virginia Commonwealth University researchers have sequenced the genome of a bacteria found in the human mouth that can cause dangerous infections.

Theranostics Health, LLC, that will use their technology to provide critical new services to medical professionals on the front line of the war on cancer.

A St. Jude study of changes in gene activity and metabolic enzymes show how cells respond to a sudden decrease in the levels of Coenzyme A.

According to AstraZenec, the facility will strengthen the global PR&D programmes as well as provide support to the existing Drug Discovery programme at Bangalore.